Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
NYU Langone Hospitals (Formerly NYU Hospitals Center)

2. Address

Address1
1 Park Avenue
 Address2
​11th Floor
City
New York
 State
NY
 Zip Code
10016
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Marc Scarduffa
​9178266625
​marc.scarduffa@nyulangone.org
5. Senate ID#
​54346-12
7. Client Name Self Check if client is a state or local government or instrumentality
​NYU Langone Hospitals (Formerly NYU Hospitals Center)
6. House ID#
​350450000
TYPE OF REPORT 8. Year
​2024
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​40,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Marc Scarduffa
 Date
4/16/2025 3:12:22 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Specific Lobbying Issues:
Medicaid/Medicare:
- Medicaid Disproportionate Share Hospital (DSH) Cuts: Advocated for elimination of cuts.

Medicare Site-Neutral Payments:
- Opposed proposed cuts to site-neutral payments.

Extension of Public Health Emergency (PHE) Waivers:
- Supported continuation of waivers for Hospital-at-Home (H@H) programs and telehealth services.

Healthcare Workforce:
- Graduate Medical Education (GME): Advocated for increased GME slots.

Improving Medicaid and CHIP Provider Enrollment Processes:
- Supported proposals to streamline enrollment.

Healthcare Programs:
- 340B Drug Pricing Program: Supported the program and opposed efforts to impose restrictive policies.
- Community Health Center Funding: Advocated for extension of funding.

Administrative Reforms:
- Prior Authorization Improvements: Supported measures to improve access to timely care.
- National Provider Identifier (NPI): Opposed proposals included in H.R. 5378 that would impact the NPI process.

Legislation Monitored and Supported/Opposed:
H.R. 7635 / S. 5021 - 340B PATIENTS Act of 2024
H.R. 8260 / S. 4350 - Hospital Inpatient Services Modernization Act
H.R. 5378 - Lower Costs, More Transparency Act
H.R. 2389 - Resident Physician Shortage Reduction Act of 2023
H.R. 9351 - Save Our Safety-Net Hospitals Act of 2024
H.R. 8702 / S. 4532 - Improving Seniors Timely Access to Care Act of 2024
H.R. 4758 - Accelerating Kids Access to Care Act
H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Meetings/letters with Congressional offices to discuss the above issues and legislative priorities. Advocacy for specific funding levels, policy changes, and program extensions.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Marc
Scarduffa
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issues:
Medicaid/Medicare:
- Medicaid Disproportionate Share Hospital (DSH) Cuts: Advocated for the elimination of cuts.
- Public Health Emergency (PHE) Waivers: Supported extension of waivers, including telehealth flexibilities and the hospital-at-home program.
- Medicare Site-Neutral Payments: Opposed proposed cuts to site-neutral payments.

Healthcare Workforce:
- Graduate Medical Education (GME): Supported increasing the number of GME slots.

Administrative Reforms:
- National Provider Identifier (NPI): Opposed burdensome policies that would impact NPI requirements under H.R. 5378.

- Prior Authorization Improvements: Advocated for measures to improve access to care and reduce administrative delays.

Healthcare Programs:
- Community Health Center Funding: Advocated for the extension of federal funding for community health centers.

- Urged members of Congress to sign the bipartisan Dear Colleague letter on Medicaid DSH, led by Representatives Clarke, Crenshaw, DeGette, and Bilirakis.

Legislation Monitored and Supported/Opposed:
- H.R. 8260 / S. 4350 - Hospital Inpatient Services Modernization Act
- H.R. 5378 - Lower Costs, More Transparency Act
- H.R. 2389 - Resident Physician Shortage Reduction Act of 2023
- H.R. 9351 - Save Our Safety-Net Hospitals Act of 2024
- H.R. 8702 / S. 4532 - Improving Seniors Timely Access to Care Act of 2024


17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Marc
Scarduffa
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Sign on to the Ad Hoc Group for Medical Research recommendation of at least the Senate Appropriations Committee-approved level of $48.9 billion for NIH

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Marc
Scarduffa
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Advocating for FEMA's Disaster Relief Fund passage in American Relief Act, 2025 (H.R. 10545)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Marc
Scarduffa
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​Gilda
​Ventresca-Ecroyd
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)